Immediate Impact
59 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Emerging role of exosomes in cancer therapy: progress and challenges
2025 Standout
Works of Shi Zuo being referenced
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors
2022
Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shi Zuo | 463 | 215 | 136 | 178 | 50 | 792 | |
| Anjian Xu | 535 | 161 | 171 | 147 | 52 | 913 | |
| María Arechederra | 576 | 200 | 108 | 120 | 39 | 896 | |
| Zhizhen Dong | 440 | 301 | 165 | 146 | 46 | 734 | |
| Hyuk Moon | 477 | 179 | 148 | 134 | 23 | 761 | |
| Yu Peng | 498 | 235 | 114 | 155 | 46 | 915 | |
| Hengyu Li | 339 | 180 | 140 | 129 | 31 | 701 | |
| Hong Zhu | 436 | 285 | 132 | 154 | 53 | 764 | |
| Guoan Xiang | 420 | 202 | 180 | 111 | 48 | 815 | |
| Romain Désert | 269 | 159 | 87 | 202 | 27 | 657 | |
| T Maass | 384 | 131 | 112 | 228 | 25 | 711 |
All Works
Login with ORCID to disown or claim papers
Loading papers...